Friday, 16 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleNasdaq· April 17, 2026

Stocks Rally as Iran Announces Strait of Hormuz is "Completely Open"

View original at nasdaq.com
Stocks Rally as Iran Announces Strait of Hormuz is "Completely Open" The S&P 500 Index ($SPX) (SPY) today is up +0.87%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +1.33%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.86%…
Opening lines of the source · Nasdaq · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Onto Innovation upgraded to buy from hold with price target of $350

    60% confidence
  • Iran has agreed to almost everything in the negotiations and they need to get to the table with a pen

    60% confidence
  • Stripping out the technology sector, Q1 earnings are projected to increase around +3%, the weakest in two years

    60% confidence
  • Woodward Inc. initiated with outperform rating and $450 price target

    60% confidence
  • US and Iran are negotiating over a plan where US would release $20 billion in frozen Iranian assets in return for Iran giving up its stockpile of enriched uranium

    60% confidence
  • Q2 revenue forecast at $12.57 billion

    60% confidence
  • Given higher uncertainty at the moment, June is a better moment than April to decide whether an ECB interest rate response to the Iran war is necessary

    60% confidence
  • Albemarle downgraded to neutral from outperform

    60% confidence
  • The Strait of Hormuz is now completely open for commercial shipping

    60% confidence
  • Q1 S&P 500 earnings projected to climb +12% y/y

    60% confidence
  • ECB needs to stay vigilant to potential inflation risks from Iran war, but we don't have much hard evidence of second-round effects, so it's difficult to argue there's an obvious case to raise rates

    60% confidence
  • President Trump might travel to Pakistan if a deal with Iran is clinched

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com